TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Letter to the Editors: AACR Defends Policy Paper And Work Of Barker, Sigal. June 27, 2003
TCL Archive In Brief: Middle East Cancer Consortium Formed; Armitage, Mayer Elected To ASCO Positions May 24, 1996
TCL Archive Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now December 2, 1983
TCL Archive In Brief: Lame Ducks continue On NCAB; Calabresi Elected To IOM; Ravikumar Moves To Yale September 28, 1990
